1. What is the projected Compound Annual Growth Rate (CAGR) of the U.S. Joint Pain Injections Market?
The projected CAGR is approximately 8.9%.
+1 2315155523
MR Forecast provides premium market intelligence on deep technologies that can cause a high level of disruption in the market within the next few years. When it comes to doing market viability analyses for technologies at very early phases of development, MR Forecast is second to none. What sets us apart is our set of market estimates based on secondary research data, which in turn gets validated through primary research by key companies in the target market and other stakeholders. It only covers technologies pertaining to Healthcare, IT, big data analysis, block chain technology, Artificial Intelligence (AI), Machine Learning (ML), Internet of Things (IoT), Energy & Power, Automobile, Agriculture, Electronics, Chemical & Materials, Machinery & Equipment's, Consumer Goods, and many others at MR Forecast. Market: The market section introduces the industry to readers, including an overview, business dynamics, competitive benchmarking, and firms' profiles. This enables readers to make decisions on market entry, expansion, and exit in certain nations, regions, or worldwide. Application: We give painstaking attention to the study of every product and technology, along with its use case and user categories, under our research solutions. From here on, the process delivers accurate market estimates and forecasts apart from the best and most meaningful insights.
Products generically come under this phrase and may imply any number of goods, components, materials, technology, or any combination thereof. Any business that wants to push an innovative agenda needs data on product definitions, pricing analysis, benchmarking and roadmaps on technology, demand analysis, and patents. Our research papers contain all that and much more in a depth that makes them incredibly actionable. Products broadly encompass a wide range of goods, components, materials, technologies, or any combination thereof. For businesses aiming to advance an innovative agenda, access to comprehensive data on product definitions, pricing analysis, benchmarking, technological roadmaps, demand analysis, and patents is essential. Our research papers provide in-depth insights into these areas and more, equipping organizations with actionable information that can drive strategic decision-making and enhance competitive positioning in the market.
U.S. Joint Pain Injections MarketU.S. Joint Pain Injections Market by Product (Corticosteroid Injections, Hyaluronic Acid Injections, Platelet Rich Plasma Injections, Others), by Joint Type (Knee, Hip, Hand & Wrist, Others), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), by Forecast 2026-2034
The U.S. Joint Pain Injections Market size was valued at USD 1.96 USD Billion in 2023 and is projected to reach USD 3.56 USD Billion by 2032, exhibiting a CAGR of 8.9 % during the forecast period. The U.S. joint pain injection market seeks to fill in the demand for the best treatments for knee and other pain resulting from conditions like arthritis and musculoskeletal disorders. It presents a complex regimen using such injections as corticosteroids, hyaluronic acid, and a PRP as well as stem cell therapies. These injections are applications by doctors to relieve the pains, reduce inflammations, and enhance a patient’s joint function who suffers from osteoarthritis, rheumatoid arthritis, and sports injuries. Among those treatments, we have corticosteroids which are injected intra-articular, Visco supplementation, hyaluronic acid, and PRP but also stem cell injections. Biotechnology and regenerative medicine applications have been much stimulated over the years by the technological advancements that together, lead to greater treatment effectiveness and safety. The joint pain injections, that are effectuating, help relieve pain, improve mobility, and prevent surgery for a while, which, in turn, contribute to a raised level of quality of life. Some of the most significant benefits are that targeted pain therapies occur, minimally invasive travel is possible, there is only a need for less time to recover, and long-term relief can be achieved, therefore, they grow to be of great importance in strategies for joint pain management.
| Aspects | Details |
|---|---|
| Study Period | 2020-2034 |
| Base Year | 2025 |
| Estimated Year | 2026 |
| Forecast Period | 2026-2034 |
| Historical Period | 2020-2025 |
| Growth Rate | CAGR of 8.9% from 2020-2034 |
| Segmentation |
|
Note*: In applicable scenarios
Primary Research
Secondary Research
Involves using different sources of information in order to increase the validity of a study
These sources are likely to be stakeholders in a program - participants, other researchers, program staff, other community members, and so on.
Then we put all data in single framework & apply various statistical tools to find out the dynamic on the market.
During the analysis stage, feedback from the stakeholder groups would be compared to determine areas of agreement as well as areas of divergence
The projected CAGR is approximately 8.9%.
Key companies in the market include Sanofi (France), SEIKAGAKU CORPORATION (Japan), Bioventus (U.S.), Anika Therapeutics, Inc. (U.S.), Pacira BioSciences, Inc. (U.S.), Dr. Reddy’s Laboratories Ltd. (India), Zimmer Biomet (U.S.), Teva Pharmaceutical Industries Ltd. (Israel), Ferring B.V. (Switzerland).
The market segments include Product, Joint Type, Distribution Channel.
The market size is estimated to be USD 1.96 USD Billion as of 2022.
Rising Prevalence of Brain Cancer Cases to Propel Market Growth.
Increasing Number of Hospitals and ASCs Identified as Significant Market Trend.
Complications Associated with the Administration of Joint Pain Injections.
April 2022 – Dr. Reddy’s Laboratories Ltd. launched Methylprednisolone Sodium Succinate for Injection, USP. It is a generic equivalent of SOLU-MEDROL in the U.S. for the treatment of blood disorders, arthritis, and other allergic conditions.
Pricing options include single-user, multi-user, and enterprise licenses priced at USD 2850, USD 3850, and USD 4850 respectively.
The market size is provided in terms of value, measured in USD Billion and volume, measured in Tons .
Yes, the market keyword associated with the report is "U.S. Joint Pain Injections Market," which aids in identifying and referencing the specific market segment covered.
The pricing options vary based on user requirements and access needs. Individual users may opt for single-user licenses, while businesses requiring broader access may choose multi-user or enterprise licenses for cost-effective access to the report.
While the report offers comprehensive insights, it's advisable to review the specific contents or supplementary materials provided to ascertain if additional resources or data are available.
To stay informed about further developments, trends, and reports in the U.S. Joint Pain Injections Market, consider subscribing to industry newsletters, following relevant companies and organizations, or regularly checking reputable industry news sources and publications.